Decision Defensibility · Life Sciences · GMP

Ten Inspection Failures.
One Missing Record.

A complete regulatory failure library for GMP compliance professionals — built from real FDA 483 observation patterns, with Decision Defense Record reconstructions for each.

10
Inspection Case Files
10
DDR Reconstructions
21 CFR
Regulatory Anchoring
4
Components Per File
483 Pattern

Regulatory observations frequently occur not because evidence is missing — but because the authorization decision connecting evidence to conclusion was never recorded.

The Questions Your Team Cannot Currently Answer

If an investigator walked in today, could you reconstruct every authorization decision?

I don't know if my CAPA disposition rationale will hold up under inspection.

The inspector is going to ask who made this call and I'm not sure we can reconstruct it.

We have six weeks before the audit and I'm not confident our decision trail is complete.

I need something that shows we thought this through — not just that we did it.

These are not documentation problems. They are decision authorization problems. Most organizations can produce SOPs, training records, and CAPA logs. What they cannot reconstruct is who authorized a specific compliance decision, based on what evidence, at what moment, and why that decision was justified.

That is the gap FDA investigators exploit. The Inspection Case File Series shows exactly how it happens — and exactly what the authorization record should have contained.

The Inspection Pattern

The observation is never about the work. It's about the authorization record that didn't exist.

What Organizations Have
  • Completed investigation reports
  • Deviation records with quality signatures
  • OOS reports with retest results
  • Batch records with release stamps
  • Change control packages with section sign-offs
  • Cleaning validation reports with data
  • CAPA records with effectiveness checks
  • Stability reports with trending data
What FDA Asks For
  • Who authorized this conclusion?
  • What evidence was evaluated before that decision?
  • How was risk assessed at the moment of authorization?
  • Who confirmed the assignable cause was verified — not suspected?
  • What was the documented basis for releasing this batch?
  • Who reviewed the totality of qualification evidence?
  • Was the monitoring period sufficient to confirm effectiveness?
  • Who authorized the shelf life conclusion?

The Series

Ten Case Files. Ten Decision Points. Ten DDR Reconstructions.

Each case file presents a real FDA 483 observation pattern, the exact inspector question that triggered it, the decision gap analysis, the inspection consequence — and a complete Decision Defense Record showing what the authorization record should have contained.

Case File #01
Process Validation Conclusion
The Data Passed. The Authorization Did Not.
21 CFR 211.100 · 21 CFR 211.192 · GAMP 5
Case File #02
Deviation Closure Authorization
The Investigation That Stopped Short
21 CFR 211.192 · 21 CFR 211.113 · FDA Aseptic Guidance
Case File #03
OOS Investigation Conclusion
The Result Was Explained. The Decision Was Not.
21 CFR 211.160 · 21 CFR 211.192 · FDA OOS Guidance 2006
Case File #04
Batch Release Authorization
The Release Was Signed. The Decision Was Not.
21 CFR 211.22(a) · 21 CFR 211.188 · 21 CFR 211.192
Case File #05
Change Control Risk Authorization
The Change Was Implemented. The Risk Decision Was Not.
21 CFR 211.100(a) · ICH Q10 · Regulatory Filing Impact
Case File #06
Cleaning Validation Acceptance
The Data Passed. The Conclusion Was Never Authorized.
21 CFR 211.67 · FDA Cleaning Validation Guidance 2023
Case File #07
CAPA Effectiveness Determination
The Actions Were Taken. The Effectiveness Was Never Verified.
21 CFR 211.192 · ICH Q10 · Recurrence Analysis
Case File #08
Supplier Qualification Decision
The Supplier Was Approved. The Authorization Was Not.
21 CFR 211.22 · 21 CFR 211.80 · 21 CFR 211.84
Case File #09
Data Integrity Remediation Decision
The Remediation Was Declared Complete. The Authorization Was Not.
21 CFR Part 11 · 21 CFR 211.68 · FDA DI Guidance 2018
Case File #10
Stability Program Conclusion
The Data Was Reviewed. The Shelf Life Was Never Authorized.
21 CFR 211.137 · 21 CFR 211.166 · ICH Q1A(R2)
Free Download · No Credit Card Required

Get Case File #3 Free.
See the standard before you buy.

The complete OOS Investigation Conclusion case file — 483 observation, decision gap analysis, inspection consequence, and full DDR reconstruction. Delivered to your inbox immediately.

📋
Case File #03 · Free
OOS Investigation Conclusion
The Result Was Explained. The Decision Was Not.

Delivered instantly · No spam · Unsubscribe anytime

Check your inbox — Case File #3 is on its way to you now.

Structure of Each Case File

Every case file follows the same four-component inspection architecture.

01

The 483 Observation

The exact FDA observation language and inspection question that triggered it — written in inspection-grade regulatory prose.

02

The Decision Gap Analysis

Evidence Present vs. Evidence Missing — the precise authorization elements absent from the record when the investigator arrived.

03

The Inspection Consequence

The real operational cost: retrospective reviews, portfolio reassessments, re-inspection commitments, and the cascade that follows.

04

The DDR Reconstruction

A complete Decision Defense Record showing what the authorization record should have contained — inspection-ready, at the moment of decision.

Decision Defense Record — Standard Structure
Decision Statement
The formal authorization of the compliance conclusion in inspection-ready language
Regulatory Context
Applicable CFR citations, guidance documents, and regulatory standard referenced
Evidence Considered
Complete enumeration of records, data, and assessments reviewed prior to authorization
Risk Evaluation
Documented risk assessment with patient safety and quality impact determination
Decision Owner
Named individual with formal accountability statement for the conclusion
Timestamped Authorization
Moment of authorization — distinct from review signature or record closure
Inspection-Ready Rationale
The complete documented basis, answerable under direct regulatory scrutiny

Who This Is For

Built for compliance professionals operating in inspection-governed environments.

Primary

Quality Assurance Leaders

QA directors and managers responsible for inspection readiness who need to demonstrate that authorization logic — not just activity — is documented at every critical decision point.

Primary

Validation & CSV Specialists

Professionals managing process validation, cleaning validation, and computer system validation who need to understand the authorization standard regulators apply to validation conclusions.

Primary

Regulatory Affairs Professionals

RA leaders supporting inspection preparation, 483 response development, and warning letter remediation who need to understand what documented decision authorization looks like in practice.

High Signal

Recent 483 Recipients

Organizations that have received an observation related to decision documentation failures — and need to understand both the gap and the standard for remediation.

High Signal

Pre-PAI Preparation Teams

Manufacturing and quality teams within six months of a Pre-Approval Inspection who need to audit their decision authorization trail before the agency does.

High Signal

Warning Letter Respondents

Compliance programs rebuilding quality systems following FDA enforcement — where the authorization record standard is now the baseline, not the aspiration.

Pricing

The complete regulatory failure library for GMP decision defensibility.

Ten inspection-grade case files. Ten DDR reconstructions. Immediate download. No subscription.

Individual Case File
$375
per case file

Access any single case file. Choose the regulatory area most relevant to your current inspection exposure.

  • One complete case file
  • Full DDR reconstruction
  • Immediate download
Secure checkout via Stripe
Complete Series Bundle
$2,997
all 10 case files · save $753

The complete 10-case regulatory failure library. Every GMP decision point. Every DDR reconstruction. The full inspection-exposure narrative from validation through stability.

  • All 10 Inspection Case Files
  • 10 complete DDR reconstructions
  • Full GMP decision lifecycle coverage
  • 21 CFR and ICH regulatory anchoring throughout
  • Immediate download — all formats
  • Suitable for team distribution and inspection preparation
Get the Complete Series — $2,997
Secure checkout via Stripe · Instant delivery
"The signature said 'reviewed.'
The DDR says 'authorized, by this person, based on this evidence, for these reasons, at this moment.'"
That is the difference between an observation and a defensible record.
Get the Complete Series